Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

25 Jul 2013 07:00

RNS Number : 0744K
Halma PLC
25 July 2013
 



Halma plc

 

AGM/Interim Management Statement

 

25 July 2013

 

 

Halma, the leading safety, health and environmental technology group is holding its 119th AGM later today and makes the following Interim Management Statement relating to the period 31 March 2013 to date, with the figures below relating to the first quarter's trading.

 

Trading since the start of the financial year has been in line with the Board's expectations.

 

Revenue during the first quarter was 13% ahead of last year including 6% organic growth at constant currency. Order intake was 103% of revenue. We continue to increase investment in R&D resources, people development and the expansion of our global footprint to support organic growth.

 

Revenue growth was achieved in all major regions, with good organic growth in Mainland Europe and Asia Pacific, the latter supported by a continued strong performance in China. Organic growth rates were lower in the UK and the USA.

 

Our Process Safety and Medical sectors performed well whilst Infrastructure Safety has continued to grow steadily.

 

Environmental & Analysis has traded in line with expectations. The reorganisation of certain Photonics and Water businesses in this sector is progressing well. This will be completed by the end of 2013 and reorganisation costs will be in line with our previous estimate of £1m.

 

There have been no material events or transactions during the period impacting the Group's financial position, which remains strong. We continue to identify potential acquisition opportunities which meet our strategic and financial criteria.

 

The half yearly results for the period ending 28 September 2013 are expected to be released on 19 November 2013.

 

 

For further information please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

 

NOTE TO EDITORS

 

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

 

·; Process Safety

Products which protect assets and people at work.

·; Infrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

 

·; Medical

Products used to improve personal and public health.

·; Environmental & Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

 

The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential. Many Group businesses are market leaders in their specialist field.

 

2.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma plc, in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

3.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMGZNDDRGFZM
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.